Nascent Pharma Holdings, Inc. (NASC)

Nascent Pharma Holdings Revenue

Nascent Pharma Holdings had revenue of $15.27K in the quarter ending September 30, 2024, a decrease of -96.36%. This brings the company's revenue in the last twelve months to $1.03M, down -57.73% year-over-year. In the year 2023, Nascent Pharma Holdings had annual revenue of $2.16M, down -67.76%. That makes Nascent Pharma Holdings the 43,555th largest company in the world by revenue and 6,090th in the United States.

• Revenue (ttm): 1.03M
• Revenue Growth: -57.73%
• P/S Ratio: 2.13
• Revenue / Employee: 86.13K
• Employees: 12
• Market Cap: 2.20M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.16M	-4.53M	-67.76%
Dec 31, 2022	6.69M	2.08M	45.22%
Dec 31, 2021	4.60M	2.89M	169.28%
Dec 31, 2020	1.71M	-595.83K	-25.84%
Dec 31, 2019	2.31M	1.64M	244.82%

Data Source: S&P Global Market Intelligence Last updated: Nov 19, 2024

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 16, 2026

Data Sources Report a data error